CRMD Cormedix Inc

Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases.

$8.05  -1.32 (-14.09%)
As of 04/14/2021 13:02:16 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/13/2010
Outstanding shares:  38,024,194
Average volume:  523,511
Market cap:   $356,286,698
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    21900C308
ISIN:        US21900C3088
Sedol:      BJ0LT31
Valuation   (See tab for details)
PE ratio:   -16.17
PB ratio:   7.10
PS ratio:   0.00
Return on equity:   -49.81%
Net income %:   -9,207.70%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy